INDIAN PHARMACEUTICAL COMPANIES are hungry for the next frontier: drugs to fight obesity, a condition that has become the biggest worry for the urban well-off as they gorge on calorie-dense food (read: junk and fast food) and lead unhealthy lifestyles.
Anti-obesity drugs are big business in the West, where obesity has reached epic proportions (according to the Global Obesity Observatory, 36.47 per cent of the US adult population is obese). As well-travelled Indians bring back the pills, Indian companies have scoped the business and want a share of the action.
Indian pharma companies already have a spectrum of drugs to tackle diabetes and a clutch of other medical conditions that are linked to obesity. But they are looking at specific pills to fight obesity as people want such pills from their doctor. “There has been a perceptible trend… among upper-income group obese patients who have connections in other countries where these drugs are accessible,” says Dr Anoop Misra, Chairman, Fortis C-DOC Hospital. “Many of these individuals have received recommendations for these drugs from relatives residing in Western countries, where such medications are widely used,” says Misra who is also the Director at National Diabetes, Obesity & Cholesterol Foundation.
Indians are not giving up on the usual tools such as diet and exercise to control weight. But these tools don’t work so well for the obese. Note: All obese people are overweight, but not all overweight people are obese. If you are the average Indian at 5 feet 6 inches tall (So says online data platform Statista, quoting a 2019 survey), and weigh 70 kg, you have just entered the overweight class (body mass index or BMI of 25.3). If you are 115 kg and above at that height, you are obese.
THE BIG SHOTS
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Pension Scheme - Safety Net
The move to introduce the UPS has evoked mixed reactions. Analysts believe its funding will have limited impact on the fiscal math
The Reit Choice?
Real Estate Investment Trusts (Reits) Are Gaining Traction As Interest Rates Stabilise. But Returns Could Be Affected By Adverse Economic Conditions And Market Volatility
CORPORATE - Calling to Account
The sudden exit of Byju's auditor BDO marks the latest in a long series of setbacks for the edtech firm
EMPLOYMENT: Skills Push
The skill development ministry plans to partner with the UGC to improve the employability of undergraduates
Building on a Vision
L&T'S CHAIRMAN EMERITUS A. M. NAIK HAS BUILT A MAMMOTH ENTERPRISE THAT IS BUILDING A NEW INDIA, FROM ITS METRO RAIL SYSTEMS TO THE RAM TEMPLE
"KYS more important than KYC"
Vijay Kedia is a renowned equity investor; the value of his listed portfolio stands at around ₹1,750 crore
ROXX STAR
THE THAR ROXX COMBINES LUXURY WITH PERFORMANCE TO MAKE A STRONG STATEMENT IN THE MID-SIZE SUV SEGMENT
HIT THE GROUND RUNNING
Smartwatches have become indispensable tools for runners, offering real-time insights into pace, distance, heart rate, and more. Here are a few you can consider
TURNING THE TABLES
INDIA'S FURNITURE MARKET IS POISED FOR A GLOBAL TAKE-OFF. ALREADY, A HOST OF GLOBAL BRANDS HAVE MADE THE COUNTRY THEIR HOME, BUT INDIAN COMPANIES ARE NOT TOO FAR BEHIND
THE EVOLUTION OF ATHERA
IDENTIFYING OPPORTUNITIES IN ADVANCE HAS STOOD THIS BENGALURU-BASED VC FUND IN GOOD STEAD. NOW, WITH A HEIGHTENED FOCUS ON TECHNOLOGY, IT WANTS TO SUSTAIN THE SUCCESS